AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12566753
Drug: Flutamide plus
RxNorm normalized name: Flutamide
DrugBank: Flutamide (DB00499)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flutamide plus oral contraceptive
Trial: 819984
Drug: Taurine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taurine (200 mg/Kg i.v. administration) for 15 consecutive days, then once a week for 6 weeks
Trial: 819984
Drug: Taurine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taurine (200 mg/Kg i.v. administration)
Trial: 25458646
Drug: Bivalirudin infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bivalirudin infusion
Trial: 31883294
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (UFH) infusion
Trial: 25252593
Drug: Nd:YAG laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nd:YAG laser treatment (1W, 100mj, 1064nm)
Trial: 23551409
Drug: Yangxue Qingnao
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yangxue Qingnao Granules (YXQNG) 12 g/day
Trial: 23551409
Drug: Nimodipine 30
RxNorm normalized name: nimodipine 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimodipine 30 mg/day
Trial: 21300177
Drug: KAN-DO intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KAN-DO intervention (mailed family kits encouraging healthy lifestyle change, 8 monthly kits, motivational counseling calls, and a single group session)
Trial: 15309209
Drug: Angiotensin converting
RxNorm normalized name: Angiotensin converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin converting enzyme inhibitors (ACE inhibitors)
Trial: 15309209
Drug: Thiazide diuretics
RxNorm normalized name: althiazide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiazide diuretics (high doses)
Trial: 15309209
Drug: Thiazide diuretics
RxNorm normalized name: althiazide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiazide diuretics (lower doses)
Trial: 15309209
Drug: ACE inhibitors
RxNorm normalized name: ACE INHIBITORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitors (in general)
Trial: 11913304
Drug: ARM &
RxNorm normalized name: Arm & Hammer Peroxicare Toothpaste
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ARM & HAMMER Dental Care The Baking Soda Gum (AHDC) - sugar-free chewing gum, 2 pieces, twice a day for 20 minutes
Trial: 11913304
Drug: breath mints
FDA approved: no
EMA approved: no
PMDA approved: no
Description: breath mints (study placebo), twice a day
Trial: 8260118
Drug: Continuous sulphonylurea
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous sulphonylurea therapy (glibenclamide for 16 weeks)
Trial: 8260118
Drug: Intermittent sulphonylurea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent sulphonylurea therapy (glibenclamide for 2 weeks then placebo for 2 weeks for 16 weeks)
Trial: 3733281
Drug: Buffered preparations
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buffered preparations
Trial: 3733281
Drug: Plain compressed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain compressed aspirin
Trial: 17598653
Drug: Fluvastatin XL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin XL 80 mg/d for 4 weeks
Trial: 15858933
Drug: Cilostazol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilostazol (200 mg/day) with aspirin (100 mg/day)
Trial: 15858933
Drug: Ticlopidine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlopidine (200 mg/day) with aspirin (100 mg/day)
Trial: 7644776
Drug: Zardaverine (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zardaverine (1.5 mg, 3.0 mg, or 6.0 mg)
Trial: 7644776
Drug: Salbutamol (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salbutamol (0.3 mg)
Trial: 1259126
Drug: Fentanyl (0.01
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (0.01 mg/kg, n = 7)
Trial: 1259126
Drug: Althesin (0.075
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Althesin (0.075 mg/kg, n = 9)
Trial: 31178967
Drug: PR antioxidant
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PR antioxidant group (α‐tocopherol: 30 mg/day, ascorbate: 180 mg/day, zinc gluconate: 15 mg/day, selenomethionine: 50 μg/day)
Trial: 28677877
Drug: BMS-986231 (3,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BMS-986231 (3, 5, 7 or 12 µg/kg/min)
Trial: 23908084
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg flurbiprofen axetil intravenously 15 minutes before surgical incision and 6 hours later (group F)
Trial: 23908084
Drug: Intravenous 5
RxNorm normalized name: immune globulin intravenous 5% intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous 5 mL intralipid as a control (group C)
Trial: 21983214
Drug: MF-59-adjuvanted influenza
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MF-59-adjuvanted influenza vaccine (Novartis Vaccines)
Trial: 21983214
Drug: Trivalent inactivated
RxNorm normalized name: diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tdvax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trivalent inactivated influenza vaccine subunit (GSK)
Trial: 11777291
Drug: Simvastatin 120
RxNorm normalized name: Simvastatin
DrugBank: Simvastatin (DB00641)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simvastatin 120 mg
Trial: 10190709
Drug: Topical ofloxacin
RxNorm normalized name: Ofloxacin
DrugBank: Ofloxacin (DB01165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical ofloxacin 0.3% (OFLX), 0.25 ml topically bid for 10 days
Trial: 10190709
Drug: Systemic amoxicillin/clavulanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic amoxicillin/clavulanate (AUG), 40 mg/kg per day for 10 days
Trial: 10190709
Drug: Topical ofloxacin
RxNorm normalized name: Ofloxacin
DrugBank: Ofloxacin (DB01165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical ofloxacin 0.3% (OFLX)
Trial: 10190709
Drug: Systemic amoxicillin/clavulanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic amoxicillin/clavulanate (AUG)
Trial: 10190709
Drug: Topical ofloxacin
RxNorm normalized name: Ofloxacin
DrugBank: Ofloxacin (DB01165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical ofloxacin 0.3% (OFLX) and Systemic amoxicillin/clavulanate (AUG)
Trial: 3052183
Drug: Captopril (C)
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Captopril (C) 25 mg tid
Trial: 3052183
Drug: Nicardipine (N)
DrugBank: Nicardipine (DB00622)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicardipine (N) 20 mg tid
Trial: 29292054
Drug: Beclomethasone 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone 100 mcg plus Formoterol 6 mcg (BDP/F)
Trial: 29292054
Drug: Fluticasone 125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone 125 mcg plus Salmeterol 25 mcg (FP/S)
Trial: 28895794
Drug: Synbiotics (Probinul
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synbiotics (Probinul Neutro, CadiGroup, Rome, Italy), 5 g powder packets dissolved in water three times a day for 30 days
Trial: 21317794
Drug: TBR-652 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TBR-652 25 mg
Trial: 21317794
Drug: TBR-652 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TBR-652 50 mg
Trial: 21317794
Drug: TBR-652 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TBR-652 75 mg
Trial: 21317794
Drug: TBR-652 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TBR-652 150 mg
Trial: 19268976
Drug: Levodopa combined
RxNorm normalized name: Levodopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levodopa combined with language therapy
Trial: 12775198
Drug: Supervised physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supervised physical therapy with a home program
Trial: 10843028
Drug: Intramuscular ceftriaxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular ceftriaxone 50 mg/kg
Trial: 10843028
Drug: No second
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No second dose of ceftriaxone
Trial: 2467496
Drug: Acrivastine 8
RxNorm normalized name: acrivastine 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acrivastine 8 mg t.d.s.
Trial: 2467496
Drug: Hydroxyzine hydrochloride
RxNorm normalized name: hydroxyzine hydrochloride
DrugBank: Hydroxyzine (DB00557)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydroxyzine hydrochloride 20 mg t.d.s.
Trial: 23680059
Drug: Insulin (INS)
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin (INS)
Trial: 24579987
Drug: First-generation drug-eluting
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First-generation drug-eluting stents (DES)
Trial: 20092882
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (lithium plus valproate)
Trial: 18447213
Drug: Tiaoshen Fuyin
RxNorm normalized name: MENTHOL 3 g TRANSDERMAL PATCH [TIANHE GUBEN YAOSHEN TIE GAO]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiaoshen Fuyin acupuncture therapy combined with language training
Trial: 1524913
Drug: ciprofloxacin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ciprofloxacin (1 g/day)
Trial: 1524913
Drug: co‐trimoxazole (1920
FDA approved: no
EMA approved: no
PMDA approved: no
Description: co‐trimoxazole (1920 mg/day) plus colistin (800 mg/day)
Trial: 3516703
Drug: Pirmenol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirmenol (50 mg intravenous injection followed by 2.5 mg min‐1 infusion)
Trial: 3516703
Drug: Lidocaine (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (75 mg injection followed by 3 mg min‐1 infusion)
Trial: 27257049
Drug: Concomitant Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant Therapy (CT)
Trial: 24102806
Drug: Autologous cord
RxNorm normalized name: Autologous cord blood
DrugBank: Autologous cord blood (DB17926)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous cord blood infusion
Trial: 20884874
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (increased during fasting)
Trial: 1505413
Drug: Dapsone-pyrimethamine (50-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapsone-pyrimethamine (50-100 mg dapsone and 6.25-12.5 mg pyrimethamine weekly)
Trial: 23213757
Drug: Epley's manoeuvre
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epley's manoeuvre plus labyrinthine sedative (Betahistine mesilate, flunarizine hydrochloride, Ginkgo biloba)
Trial: 8549941
Drug: Cholestyramine 4
RxNorm normalized name: CHOLESTYRAMINE 4GM CHEW BAR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholestyramine 4 g twice daily
Trial: 8549941
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of simvastatin and cholestyramine
Trial: 42976
Drug: Mouth and
RxNorm normalized name: Oracoat Xyligel Dry Mouth And Lip Citrus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mouth and throat disinfectant lozenges (sugar-containing)
Trial: 42976
Drug: Sugar-free mouth
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugar-free mouth and throat disinfectant lozenge
Trial: 31552551
Drug: Vortioxetine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vortioxetine (10 mg single dose, 10 mg and 20 mg multiple daily doses)
Trial: 28373452
Drug: TACE using
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TACE using drug-eluting beads (DEBs) loaded with doxorubicin
Trial: 28373452
Drug: TACE using
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TACE using polyethylene glycol drug-elutable microspheres (PEG) loaded with doxorubicin
Trial: 23900878
Drug: Macitentan (1-30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Macitentan (1-30 mg)
Trial: 17493004
Drug: Curcumin 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin 30 mg b.i.d., bovine lactoferrin 100 mg b.i.d., N-acetylcysteine 600 mg b.i.d., pantoprazole 20 mg b.i.d.
Trial: 15833589
Drug: Cortisol (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cortisol (0.2 mg/kg)
Trial: 15833589
Drug: Cocaine (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine (0.2 mg/kg)
Trial: 12042201
Drug: Olanzapine plus
RxNorm normalized name: Olanzapine
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olanzapine plus fluoxetine (10 mg/day olanzapine, 20 mg/day fluoxetine)
Trial: 12042201
Drug: Olanzapine plus
RxNorm normalized name: Olanzapine
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olanzapine plus placebo (10 mg/day olanzapine, placebo)
Trial: 2652217
Drug: Cimetidine (CMT)
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cimetidine (CMT) 400 mg/night
Trial: 2652217
Drug: Ranitidine (RNT)
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine (RNT) 150 mg/night
Trial: 1100308
Drug: Intramuscular phenytoin
RxNorm normalized name: Phenytoin
DrugBank: Phenytoin (DB00252)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular phenytoin
Trial: 28191694
Drug: RCT sample
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RCT sample treatment effects (weighted)
Trial: 10827334
Drug: 1-implant group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-implant group
Trial: 28389025
Drug: 2-implant group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-implant group
Trial: 10827334
Drug: Nestorone(R) implants
RxNorm normalized name: pantolactone, (R)-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nestorone(R) implants
Trial: 26916733
Drug: MDCO-216 (5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDCO-216 (5, 10, 20, 30, and 40 mg/kg) infused over 2 hours
Trial: 26916733
Drug: MDCO-216 (high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDCO-216 (high doses)
Trial: 24373344
Drug: Intravitreal bevacizumab
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intravitreal bevacizumab (IVB) - 3 monthly injections of 1.25 mg
Trial: 24373344
Drug: Intravitreal triamcinolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal triamcinolone (IVT) - 2 injections of 2 mg 2 months apart
Trial: 17497754
Drug: Sample preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sample preparation (liquid‐liquid extraction)
Trial: 11862975
Drug: Chronic alacepril
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic alacepril treatment (12 weeks)
Trial: 11862975
Drug: Acute alacepril
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute alacepril treatment
Trial: 7554760
Drug: L-arginine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (10 g, systemic infusion, n = 5)
Trial: 7554760
Drug: D-arginine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-arginine (10 g, systemic infusion, n = 3)
Trial: 7554760
Drug: L-arginine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (40 mumol/l, forearm vascular bed infusion)
Trial: 7554760
Drug: D-arginine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-arginine (40 mumol/l, forearm vascular bed infusion)
Trial: 30543339
Drug: Bevacizumab plus
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab plus standard-of-care treatment beyond disease progression
Trial: 26854355
Drug: 3-module group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-module group treatment (cognitive, exposure, skills) for PTSD
Trial: 22919989
Drug: 0.1% Tacrolimus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% Tacrolimus ointment twice a day
Trial: 22919989
Drug: 0.05% Clobetasol
RxNorm normalized name: CLOBETASOL PROPIONATE 0.5 mg in 1 g TOPICAL CREAM [Clobetasol Propionate Cream, 0.05% Clobetasol Propionate Cream, 0.05%]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05% Clobetasol propionate ointment once a day
Trial: 20090326
Drug: Control sugar
RxNorm normalized name: Meta Appetite Control Sugar-Free Powder for Suspension (Orange Zest)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control sugar (65% sucrose + 33% glucose syrup)
Trial: 2495891
Drug: Triphasic preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triphasic preparation
Trial: 28139259
Drug: Dalteparin 5000
RxNorm normalized name: dalteparin 5000 intl units/0.2 mL subcutaneous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalteparin 5000 units daily for 12 weeks
Trial: 16555157
Drug: Parenteral nutrition
RxNorm normalized name: parenteral nutrition solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral nutrition (PN group, n=20)
Trial: 11263281
Drug: Drug-penetration and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-penetration and oral administration of traditional Chinese decoction plus traction
Trial: 11263281
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of Chinese decoction and traction
Trial: 8644682
Drug: Daily iron
RxNorm normalized name: Walgreens Multivitamin One Daily Iron-Free Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily iron supplementation (60 mg Fe/d)
Trial: 8644682
Drug: Weekly iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly iron supplementation (120 mg Fe/wk)
Trial: 8644682
Drug: Daily iron
RxNorm normalized name: Walgreens Multivitamin One Daily Iron-Free Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily iron supplementation (60 mg Fe/d) in subgroup (n = 45)
Trial: 8644682
Drug: Weekly iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly iron supplementation (120 mg Fe/wk) in subgroup (n = 54)
Trial: 8644682
Drug: Compliance in
RxNorm normalized name: B-12 Compliance Injection Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compliance in daily group
Trial: 8644682
Drug: Compliance in
RxNorm normalized name: B-12 Compliance Injection Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compliance in weekly group
Trial: 1687121
Drug: Alpidem 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpidem 200 mg
Trial: 1687121
Drug: Alpidem (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpidem (all doses)
Trial: 6347123
Drug: Dihydroergotamine mesylate
RxNorm normalized name: Dihydroergotamine Mesylate
DrugBank: Dihydroergotamine (DB00320)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dihydroergotamine mesylate with low-dose heparin sodium
Trial: 6390998
Drug: Low-dose heparin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose heparin alone
Trial: 30772343
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of freshly collected autologous adipose tissue
Trial: 28816707
Drug: Group exercise
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group exercise with brace adjustment twice per week
Trial: 27431233
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg tribendimidine (study 1)
Trial: 27431233
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg tribendimidine (study 2)
Trial: 27431233
Drug: ≥100 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ≥100 mg tribendimidine
Trial: 24158761
Drug: Testosterone gel
RxNorm normalized name: Androgel 1.62% Metered Dose Pump Testosterone Gel
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone gel daily for 6 months
Trial: 16248463
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no treatment in the other nasal cavity)
Trial: 12092987
Drug: 1% CHX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% CHX gel (single professional tooth cleaning)
Trial: 12092987
Drug: 1% CHX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% CHX gel (daily tooth brushing for 2 weeks)
Trial: 22288298
Drug: L-arginine 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine 6 g/24-hour
Trial: 22288298
Drug: L-arginine 12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine 12 g/24-hour
Trial: 11283865
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (IFN + AMA)
Trial: 3102127
Drug: Suprofen (prostaglandin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suprofen (prostaglandin synthetase inhibitor)
Trial: 28081351
Drug: Methylprednisolone 15
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone 15 mg/kg
Trial: 23570596
Drug: Half-dose triptorelin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half-dose triptorelin (1.875 mg each time)